Skip to main content

Regeneron Pharmaceuticals, Inc 10-Q for FY2021 Q1

Regeneron Pharmaceuticals, Inc. (REGN)

10-Q 2021-05-06 For: 2021-03-31
View Original
Added on April 08, 2026

About this 10-Q

Regeneron Pharmaceuticals, Inc filed this 10-Q on May 6, 2021, covering the quarter ended March 31, 2021 (FY2021 Q1).

Headline figures

Quarter ended March 31, 2021, as reported in this filing, compared with the same period a year earlier where the filing states it.

Revenue
$2.53B
up 38.3% from $1.83B a year earlier
Net income
$1.12B
up 78.5% from net income of $624.6M a year earlier
Diluted EPS
$10.09
up 85.8% from $5.43 a year earlier